Bionike one-step tests were used to screen urine samples for amphetamines, methamphetamines, benzodiazepines, cannabinoids, methadone and opiates, and results were compared with those obtained using enzyme multiplied immunoassay technique d.a.u. assays. Taking into consideration different threshold levels and possible differences in cross-reactivities, there was good agreement between the methods. Results of Bionike tests correlated well with amphetamines, methadone and opiates detected in urine using gas chromatography—mass spectrometry. Bionike methods are rapid, simple to use, and relatively inexpensive for on-site testing of individual drugs or groups of drugs in urine.
ArmbrusterDAKrolakJM. Screening for drugs of abuse with the Roche ONTRAK assays. J Anal Toxicol1992; 16: 172–5.
2.
TowtJTsaiS-CJHernandezMRKlimovADKravecCVRouseSLONTRAK TESTCUP: A novel, on-site, multi-analyte screen for the detection of abused drugs. J Anal Toxicol1995; 19: 504–10.
3.
BuechlerKFMoiSNoarBMcGrathDVillelaJClancyMSimultaneous detection of seven drugs of abuse by the Triage panel for drugs of abuse. Clin Chem1992; 38: 1678–84.
4.
KafersteinHStichtG. Diagnostic observations with the methadone and cannabis 50 assay on the new Triage™ 7 Panel for drugs of abuse. GIT Lab Med1994; 17: 266–70.
5.
BorlandWMcKenzieLStewartM. An assessment of the Triage drugs of abuse screening cassette. In: HalloranSPMartinSM, eds. Proceedings of the ACB National Meeting, Glasgow, 1995, May 8–12. London: RSM Press, 1995: 166.
6.
WuAHBWongSSJohnsonKGCalliesJShuDXDunnWEEvaluation of the Triage system for emergency drugs-of-abuse testing in urine. J Anal Toxicol1993; 17: 241–5.
7.
GeorgeSBraithwaiteRA. A preliminary evaluation of five rapid detection kits for on site drugs of abuse screening. Addiction1995; 90: 227–32.
8.
MooreFMLJarvieDRSimpsonD. Urinary amphetamines, benzodiazepines and methadone: Cost effective detection procedures. Med Lab Sci1992; 49: 27–33.
9.
MooreFMLSimpsonD. Detection of cannabinoids in urine: A cost-effective low risk immunoassay procedure. Med Lab Sci1991; 48: 76–9.
10.
MooreFMLSimpsonD. Detection of opiates in urine: A cost-effective low risk immunoassay procedure. Med Lab Sci1989; 46: 309–12.
11.
CraneTDawsonCMTicknerTR. False-positive results from Syva EMIT d.a.u. monoclonal amphetamine assay as a result of antipsychotic drug therapy [Letter]. Clin Chem1993; 39: 549.
12.
MooreFMLJarvieDRSimpsonD. Comparison of polyclonal and monoclonal assays for routine screening of urines for amphetamines. Ann Clin Biochem1996; 33: 78–81.
13.
KunsmanGWMannoJECockerhamKRMannoBR. Application of Syva EMIT and Abbott TDx amphetamine immunoassays to the detection of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyethamphetamine (MDEA) in urine. J Anal Toxicol1990; 14: 149–53.
14.
BrownERSJarvieDRSimpsonD. Use of drugs at “Raves”. Scott Med J1995; 40: 168–71.
15.
HausmannEKohlBVon BoehmerHWellhonerHH. False-positive EMIT indication of opiates and methadone in a doxylamine intoxication. J Clin Chem Clin Biochem1983; 21: 599–600.
16.
HobbsR. Near patient testing in primary care. BMJ1996; 312: 263–4.
17.
DHSS Hazard Notice. Blood Glucose Measurements: Reliability of Results Produced in Extra Laboratory Areas, HN (Hazard) [87]31. London: Department of Health and Social Security, 1987.
18.
DoH Hazard Notice. Blood Gas Measurements: The Need for Reliability of Results Produced in Extra Laboratory Areas, HC (Hazard) [89]31. London: Department of Health, 1989.
19.
DoH Joint Working Group on Quality Assurance. Guidelines on the Control of Near-patient Tests (NPT) and Procedures Performed. London: Department of Health, 1992.
20.
DHSSManagement of Equipment, Health Equipment Information No. 98. London: Department of Health and Social Security, 1982.
21.
DHSSProcurement Product Liability—Implications for the NHS of the Consumer Protection Act 1987. Health Notice HN(88). London: Department of Health and Social Security, 1988.
22.
KellyKL. Ranitidine cross-reactivity in the EMITR d.a.u.™ monoclonal amphetamine/methamphetamine assay. Clin Chem1990; 36: 1391–2.
